Somatic mosaicism of a CDKL5 mutation identified by next-generation sequencing

Takeshi Kato1, Naoya Morisada1, Hiroaki Nagase2

  • 1Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Brain & Development
|March 31, 2015
PubMed

Insights

A genetic analysis identified two epilepsy-associated variants in a Japanese boy with CDKL5-related encephalopathy. The CDKL5 mutation was likely the primary cause of his severe neurological symptoms.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • CDKL5-related encephalopathy is a severe X-linked disorder causing early infantile epileptic encephalopathy or atypical Rett syndrome.
  • Characterized by intractable epilepsy, severe developmental delay, and Rett syndrome-like features, with onset typically in early infancy.

Observation:

  • A 5-year-old Japanese boy presented with intractable epilepsy and severe developmental delay since 2 months of age.
  • Electroencephalogram revealed sporadic single poly spikes and diffuse irregular poly spikes.
  • Genetic analysis was performed using a next-generation sequencing panel.

Findings:

  • Two epilepsy-associated single nucleotide variants were identified: CDKL5 p.Ala40Val and KCNQ2 p.Glu515Asp.
  • The CDKL5 p.Ala40Val mutation, previously linked to early infantile epileptic encephalopathy, exhibited somatic mosaicism in the patient.
  • The KCNQ2 p.Glu515Asp variant, associated with benign familial neonatal seizures-1, was paternally inherited.

Implications:

  • The somatic mosaic CDKL5 mutation is considered the primary driver of the patient's neurological phenotype.
  • The KCNQ2 variant may also contribute to neurological effects.
  • Next-generation sequencing effectively identifies multiple genetic variants in complex neurological disorders.
Abstract